Literature DB >> 26700592

Time course of ubiquitin-proteasome and macroautophagy-lysosome pathways in skeletal muscle in rats with heart failure.

Naoto Fujita1, Hidemi Fujino, Hiroki Sakamoto, Jyunya Takegaki, Masataka Deie.   

Abstract

Patients with heart failure have limited exercise capacity due to not only the myocardial dysfunction but also skeletal muscle atrophy. However, the mechanisms and time course of protein degradation in skeletal muscle during heart failure remain unclear, and there is no established standard treatment. The purpose of the present study was to investigate the time course of major protein degradation pathways in skeletal muscle during heart failure. Four-week-old male Wistar rats were randomly assigned to heart failure induced by monocrotaline or control groups. At 14 and 21 days after monocrotaline injection, the lungs, heart, and gastrocnemius and soleus muscles were removed and analyzed. There was no significant difference in body weight between the groups at 14 days after monocrotaline injection. Although there were no morphological changes in the skeletal muscle of the monocrotaline group at this time point, ubiquitin-proteasome and macroautophagylysosome pathways were activated in the monocrotaline group. Additionally, the pathways were less strongly activated in the soleus muscle than in the gastrocnemius muscle. These results suggest that physical exercise that shifts to slow muscle characteristics should begin when there is no indication of skeletal muscle atrophy to prevent exercise intolerance with heart failure.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26700592     DOI: 10.2220/biomedres.36.383

Source DB:  PubMed          Journal:  Biomed Res        ISSN: 0388-6107            Impact factor:   1.203


  5 in total

Review 1.  Muscle wasting and cachexia in heart failure: mechanisms and therapies.

Authors:  Stephan von Haehling; Nicole Ebner; Marcelo R Dos Santos; Jochen Springer; Stefan D Anker
Journal:  Nat Rev Cardiol       Date:  2017-04-24       Impact factor: 32.419

2.  Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension.

Authors:  Naoto Fujita; Natsuki Yamasaki; Kanako Eto; Makoto Asaeda; Wataru Kuwahara; Hidetaka Imagita
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

Review 3.  Exercise as a Therapeutic Strategy for Sarcopenia in Heart Failure: Insights into Underlying Mechanisms.

Authors:  Jinkyung Cho; Youngju Choi; Pavol Sajgalik; Mi-Hyun No; Sang-Hyun Lee; Sujin Kim; Jun-Won Heo; Eun-Jeong Cho; Eunwook Chang; Ju-Hee Kang; Hyo-Bum Kwak; Dong-Ho Park
Journal:  Cells       Date:  2020-10-13       Impact factor: 6.600

4.  Neutralization of GDF15 Prevents Anorexia and Weight Loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model.

Authors:  Bina Albuquerque; Xian Chen; Dinesh Hirenallur-Shanthappa; Yang Zhao; John C Stansfield; Bei B Zhang; Abdul Sheikh; Zhidan Wu
Journal:  Cells       Date:  2022-03-23       Impact factor: 6.600

5.  Hyperbaric Normoxia Improved Glucose Metabolism and Decreased Inflammation in Obese Diabetic Rat.

Authors:  Naoto Fujita; Natsuki Goto; Tomoya Nakamura; Wataru Nino; Taketoshi Ono; Hisao Nishijo; Susumu Urakawa
Journal:  J Diabetes Res       Date:  2019-11-19       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.